Ausgabe 1/2013
Special Issue: Interdisciplinary Neuroscience
Inhalt (24 Artikel)
Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder
Thomas Dresler, Anne Guhn, Sara V. Tupak, Ann-Christine Ehlis, Martin J. Herrmann, Andreas J. Fallgatter, Jürgen Deckert, Katharina Domschke
The effect of piribedil on l-DOPA-induced dyskinesias in a rat model of Parkinson’s disease: differential role of α2 adrenergic mechanisms
Manfred Gerlach, Paul Halley, Peter Riederer, Maarten van den Buuse
Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism
Yulia Pollak, Danit Mechlovich, Tamar Amit, Orit Bar-Am, Irena Manov, Silvia A. Mandel, Orly Weinreb, Esther G. Meyron-Holtz, Theodore C. Iancu, Moussa B. H. Youdim
A possible pathophysiological role of tyrosine hydroxylase in Parkinson’s disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer
Akira Nakashima, Akira Ota, Yoko S. Kaneko, Keiji Mori, Hiroshi Nagasaki, Toshiharu Nagatsu
Peter Riederer “70th birthday” Neurobiological foundations of modern addiction treatment
Christian Jacob
Autologous stem cells in neurology: is there a future?
Johannes P. J. M. de Munter, Erik C. Wolters
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
E. Koutsilieri, M. B. Lutz, C. Scheller
‘‘70th Birthday Professor Riederer’’ Induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (−)deprenyl: a way to a disease-modifying therapy?
Wakako Maruyama, Makoto Naoi
70th Birthday symposium of Prof. Dr. Riederer: autologous adult stem cells in ischemic and traumatic CNS disorders
Johannes P. J. M. de Munter, Erik Ch. Wolters
Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer’s disease
Lezanne Ooi, Kuldip Sidhu, Anne Poljak, Greg Sutherland, Michael D. O’Connor, Perminder Sachdev, Gerald Münch
Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways
Jasmin Bartl, Andrea Meyer, Svenja Brendler, Peter Riederer, Edna Grünblatt
A systematic review on olfaction in child and adolescent psychiatric disorders
Martin Schecklmann, Christina Schwenck, Regina Taurines, Christine Freitag, Andreas Warnke, Manfred Gerlach, Marcel Romanos
In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder
Edna Grünblatt, Jasmin Bartl, Zoya Marinova, Susanne Walitza
Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats
Ivica Matak, Ivana Stracenski, Zdravko Lacković
Cortical control of saccades in Parkinson disease and essential tremor
S. Yerram, S. Glazman, I. Bodis-Wollner
Mild cognitive impairment in Parkinson disease: heterogenous mechanisms
Kurt A. Jellinger
Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment
Szilvia Vas, Zita Kátai, Diána Kostyalik, Dorottya Pap, Eszter Molnár, Péter Petschner, Lajos Kalmár, György Bagdy
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB1 receptor antagonists
E. Kirilly, L. Hunyady, G. Bagdy
Increased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophrenia
Evelin L. Schaeffer, Franziska Kühn, Angelika Schmitt, Wagner F. Gattaz, Oliver Gruber, Thomas Schneider-Axmann, Peter Falkai, Andrea Schmitt
Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?
Sagar Kansara, Akash Trivedi, Sheng Chen, Joseph Jankovic, Weidong Le
Folate and Alzheimer: when time matters
Margareta Hinterberger, Peter Fischer
The effects of most commonly prescribed second generation antidepressants on driving ability: a systematic review
Alexander Brunnauer, Gerd Laux
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research
Melita Salkovic-Petrisic, Ana Knezovic, Siegfried Hoyer, Peter Riederer